Pfizer share news, announcements and annual reports
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Pfizer Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1966 on BSE, Apr 1999 on NSE
Last close ₹3,687.80down ₹72.00 (1.92%)BSE ₹3,687.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,759.80.
30 Oct: open ₹3,760.00, high ₹3,776.90, low ₹3,668.10
52-week range of traded prices to 30 Oct 2026
₹3,589.00Low, 23 Oct 2026₹5,346.00High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16,871 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.95
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.03%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,12450.8% delivered
Pfizer results
91 filed, newest first. Page 2 of 2.
May 2014
Jan 2014
31 Jan · Results
Nov 2013
11 Nov · Results
Jul 2013
May 2013
14 May · Results
Feb 2013
Nov 2012
Aug 2012
May 2012
21 May · Results
Apr 2012
25 Apr · Results
Company proposes to announce the audited results for the financial year ended March 31, 2012 within the 60 days period as stipulated in clause 41 of the Listing Agreement. Hence, the Company will not be publishing the un-audited results for the last quarter ended March 31, 2012.
Jan 2012
Oct 2011
Aug 2011
1 Aug · Results
Standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 24187 lacs for quarter ending on 30-JUN-2011. Net Profit / (Loss) of Rs. 4124 lacs for the quarter ending on 30-JUN-2011.
May 2011
Apr 2011
11 Apr · Results
Company propose to publish the Audited Financial Results for the 16 months period ended March 31, 2011 alongwith the Un-audited Financial Results for the 4 months period from December 01, 2010 to March 31, 2011 within a period of 60 days as stipulated in Clause 41 of the Listing agreement. Therefore, Company will not be separately publishing the Un-audited Financial Results for the 5th Quarter i.e. for the 4 months period December 01, 2010 to March 31, 2011.
Jan 2011
11 Jan · Results
Standalone Results for the period ended on 30-NOV-2010 as follows: Net Sales of Rs. 23584 lacs for period ending on 30-NOV-2010 against Rs. 19494 lacs for the period ending on 30-NOV-2009. Net Profit / (Loss) of Rs. 4358 lacs for the period ending on 30-NOV-2010 against Rs. 2573 lacs for the period ending on 30-NOV-2009.
Oct 2010
6 Oct · Results
Standalone Results for the quarter ended on 31-AUG-2010 as follows: Net Sales of Rs. 22561 lacs for quarter ending on 31-AUG-2010 against Rs. 20484 lacs for the quarter ending on 31-AUG-2009. Net Profit / (Loss) of Rs. 4248 lacs for the quarter ending on 31-AUG-2010 against Rs. 4115 lacs for the quarter ending on 31-AUG-2009.
Jul 2010
12 Jul · Results
Standalone Results for the quarter ended on 31-MAY-2010 as follows: Net Sales of Rs. 21233 lacs for quarter ending on 31-MAY-2010 against Rs. 18585 lacs for the quarter ending on 31-MAY-2009. Net Profit / (Loss) of Rs. 3469 lacs for the quarter ending on 31-MAY-2010 against Rs. 3129 lacs for the quarter ending on 31-MAY-2009.
Mar 2010
26 Mar · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 28-FEB-2010 as follows: Net Sales of Rs. 20261 lacs for quarter ending on 28-FEB-2010 against Rs. 18597 lacs for the quarter ending on 28-FEB-2009. Net Profit / (Loss) of Rs. 4245 lacs for the quarter ending on 28-FEB-2010 against Rs. 3901 lacs for the quarter ending on 28-FEB-2009.
Feb 2010
25 Feb · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-NOV-2009 as follows: Net Sales of Rs. 19494 lacs for quarter ending on 30-NOV-2009 against Rs. 17622 lacs for the quarter ending on 30-NOV-2008. Net Profit / (Loss) of Rs. 2573 lacs for the quarter ending on 30-NOV-2009 against Rs. 3023 lacs for the quarter ending on 30-NOV-2008.25 Feb · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the year ended on 30-NOV-2009 as follows: Net Sales of Rs. 77160 lacs for year ending on 30-NOV-2009 against Rs. 67771 lacs for the year ending on 30-NOV-2008. Net Profit / (Loss) of Rs. 13718 lacs for the year ending on 30-NOV-2009 against Rs. 29912 lacs for the year ending on 30-NOV-2008.25 Feb · Results
Pfizer Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 30-NOV-2009 as follows: Net Sales of Rs. 77227 lacs for year ending on 30-NOV-2009 against Rs. 68170 lacs for the year ending on 30-NOV-2008. Net Profit / (Loss) of Rs. 13712 lacs for the year ending on 30-NOV-2009 against Rs. 29958 lacs for the year ending on 30-NOV-2008.
Dec 2009
23 Dec · Results
Pfizer Ltd. has informed the Exchange that "We propose to announce the Audited Financial Results for the financial year ended November 30, 2009 within the 3 months period as stipulated in Clause 41 of the Listing Agreement. Therefore, we will not be publishing the Un-audited Financial Results for the last quarter ended November 30, 2009".
Sep 2009
29 Sep · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-AUG-2009 as follows: Net Sales of Rs. 20484 lacs for quarter ending on 31-AUG-2009 against Rs. 18768 lacs for the quarter ending on 31-AUG-2008. Net Profit / (Loss) of Rs. 4115 lacs for the quarter ending on 31-AUG-2009 against Rs. 3808 lacs for the quarter ending on 31-AUG-2008.
Jun 2009
27 Jun · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAY-2009 as follows: Net Sales of Rs. 18585 lacs for quarter ending on 31-MAY-2009 against Rs. 16344 lacs for the quarter ending on 31-MAY-2008. Net Profit / (Loss) of Rs. 3129 lacs for the quarter ending on 31-MAY-2009 against Rs. 3792 lacs for the quarter ending on 31-MAY-2008.27 Jun · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 31-MAY-2009 as follows: Net Sales of Rs. 37182 lacs for half year ending on 31-MAY-2009 against Rs. 31381 lacs for the half year ending on 31-MAY-2008. Net Profit / (Loss) of Rs. 7030 lacs for the half year ending on 31-MAY-2009 against Rs. 23081 lacs for the half year ending on 31-MAY-2008.
Jan 2009
30 Jan · Results
Pfizer Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 30-NOV-2008 as follows: Net Sales of Rs. 68170 lacs for year ending on 30-NOV-2008 against Rs. 67669 lacs for the year ending on 30-NOV-2007. Net Profit / (Loss) of Rs. 29958 lacs for the year ending on 30-NOV-2008 against Rs. 34000 lacs for the year ending on 30-NOV-2007.
Dec 2008
10 Dec · Results
Pfizer Ltd. has informed the Exchange that the Company propose to announce the Audited Financial Results for the financial year ended November 30, 2008 within 3 months period as stipulated in Clause 41 of the Listing Agreement. Therefore, the Company will not be publishing the Un-audited Financial Results for the last quarter ended November 30, 2008.
Sep 2008
30 Sep · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-AUG-2008 as follows: Net Sales of Rs. 18768 lacs for quarter ending on 31-AUG-2008 against Rs. 17565 lacs for the quarter ending on 31-AUG-2007. Net Profit / (Loss) of Rs. 3808 lacs for the quarter ending on 31-AUG-2008 against Rs. 3083 lacs for the quarter ending on 31-AUG-2007.
Jun 2008
30 Jun · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 31-MAY-2008 as follows: Net Sales of Rs. 31381 lacs for half year ending on 31-MAY-2008 against Rs. 31967 lacs for the half year ending on 31-MAY-2007. Net Profit / (Loss) of Rs. 23081 lacs for the half year ending on 31-MAY-2008 against Rs. 28603 lacs for the half year ending on 31-MAY-2007.30 Jun · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAY-2008 as follows: Net Sales of Rs. 16344 lacs for quarter ending on 31-MAY-2008 against Rs. 16467 lacs for the quarter ending on 31-MAY-2007. Net Profit / (Loss) of Rs. 3792 lacs for the quarter ending on 31-MAY-2008 against Rs. 25776 lacs for the quarter ending on 31-MAY-2007.
Mar 2008
31 Mar · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 29-FEB-2008 as follows: Net Sales of Rs. 15037 lacs for quarter ending on 29-FEB-2008 against Rs. 15500 lacs for the quarter ending on 28-FEB-2007. Net Profit / (Loss) of Rs. 19289 lacs for the quarter ending on 29-FEB-2008 against Rs. 2827 lacs for the quarter ending on 28-FEB-2007.
Feb 2008
25 Feb · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the year ended on 30-NOV-2007 as follows: Net Sales of Rs. 67266 lacs for year ending on 30-NOV-2007 against Rs. 66235 lacs for the year ending on 30-NOV-2006. Net Profit / (Loss) of Rs. 33893 lacs for the year ending on 30-NOV-2007 against Rs. 10573 lacs for the year ending on 30-NOV-2006.25 Feb · Results
Pfizer Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 30-NOV-2007 as follows: Net Sales of Rs. 67669 lacs for year ending on 30-NOV-2007 against Rs. 66679 lacs for the year ending on 30-NOV-2006. Net Profit / (Loss) of Rs. 34000 lacs for the year ending on 30-NOV-2007 against Rs. 10633 lacs for the year ending on 30-NOV-2006.25 Feb · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-NOV-2007 as follows: Net Sales of Rs. 17734 lacs for quarter ending on 30-NOV-2007. Net Profit / (Loss) of Rs. 2206 lacs for the quarter ending on 30-NOV-2007.
Dec 2007
14 Dec · Results
Pfizer Ltd. has informed the Exchange that the company will publish the Audited Financial Results for the financial year ended November 30, 2007 within the 3 months period.
Sep 2007
24 Sep · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-AUG-2007 as follows: Net Sales of Rs. 17565 lacs for quarter ending on 31-AUG-2007 against Rs. 17845 lacs for the quarter ending on 31-AUG-2006. Net Profit / (Loss) of Rs. 3083 lacs for the quarter ending on 31-AUG-2007 against Rs. 2807 lacs for the quarter ending on 31-AUG-2006.
Jun 2007
28 Jun · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 31-MAY-2007 as follows: Net Sales of Rs. 31967 lacs for half year ending on 31-MAY-2007 against Rs. 31305 lacs for the half year ending on 31-MAY-2006. Net Profit / (Loss) of Rs. 28603 lacs for the half year ending on 31-MAY-2007 against Rs. 6066 lacs for the half year ending on 31-MAY-2006.28 Jun · Results
Pfizer Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAY-2007 as follows: Net Sales of Rs. 16467 lacs for quarter ending on 31-MAY-2007 against Rs. 16707 lacs for the quarter ending on 31-MAY-2006. Net Profit / (Loss) of Rs. 25776 lacs for the quarter ending on 31-MAY-2007 against Rs. 3589 lacs for the quarter ending on 31-MAY-2006.